JPRN-UMIN000010641已完成2 期
Phase II study of multi-agent chemotherapy in patients with adult Burkitt leukemia. - Study of multi-agent chemotherapy in patients with adult Burkitt leukemia. (JALSG Burkitt-ALL213)
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Previously treated with leukapheresis 2. Congestive heart failure 3. Recent history of myocardial infarction 4. Malignant hypertension 5. Lung fibrosis 6. Interstitial pneumonitis 7. Severe comorbidity (diabetes mellitus, infection or liver cirrhosis) 8. Positive anti-HIV antibody or HBs antigen 9. Thrombosis which need treatment 10. Psychological disorders 11. Other active neoplasms 12. Pregnant and/or lactating woman 13. Judged to be inadequate
研究者
相似试验
已完成
2 期
Phase II study of multi-agent chemotherapy in patients with adult precursor T acute lymphoblastic leukemia.precursor T acute lymphoblastic leukemiaJPRN-UMIN000010642Japan Adult Leukemia Study Group28
已完成
2 期
Phase II study of multi-agent chemotherapy in patients with adult Philadelphia chromosome negative precursor B acute lymphoblastic leukemia.Philadelphia chromosome negative precursor B acute lymphoblastic leukemiaJPRN-UMIN000010619Japan Adult Leukemia Study Group211
招募中
不适用
Pilot study of multiagent chemotherapy with intrathecal chemotherapy and delayed local radiotherapy in patients with atypical teratoid/rhabdoid tumors.Atypical teratoid/rhabdoid tumorJPRN-UMIN000014490Japanese Pediatric Brain Tumor Consortium10
招募中
2 期
Phase II study of combination chemotherapy using paclitaxel, carboplatin, and bevacizumab in patients with advanced or recurrent cervical cancer.cervical cancerJPRN-UMIN000024137Hyogo Cancer Center30
已完成
2 期
Phase II study of combination chemotherapy with mitomycin and methotrexate for triple negative breast cancerBreast CancerJPRN-UMIN000003512Cancer Institute Hospital, Japanese Foundation for Cancer Research70